Company record
Intellia Therapeutics, Inc.
United States
Suppliers and customers
1 supplier, 3 customers
The customers with the most current records are Kyverna Therapeutics, NOVARTIS and Regeneron Pharmaceuticals.
Regeneron Pharmaceuticals is also recorded as a supplier.
Suppliers
| Company | Country | Supplies | Latest record |
|---|---|---|---|
| Regeneron Pharmaceuticals | unknown | undisclosed | FY2020a record of the past |
Customers
| Company | Country | Buys | Latest record |
|---|---|---|---|
| Kyverna Therapeutics | unknown | undisclosed | FY2022 |
| NOVARTIS | unknown | undisclosed | FY2021 |
| Regeneron Pharmaceuticals | unknown | undisclosed | FY2024 |
Source records
Figures read 15 Nov 2026. Latest source 15 Nov 2026.
Sources, 2
- Export-control designations
- Federal Register-anchored designations0 records, 15 Nov 2026
- Supply-chain relationships
- SEC disclosures, re-derived company disclosures, licensed supply-chain database
How the figures were made
Suppliers and customers. Records are grouped by counterparty, and counterparties with more current records come first. A disclosure more than 5 years old is marked a record of the past and follows the current records with its fiscal year. A product or service appears only where the record’s cited source states it for the pair. Alternative suppliers may exist outside this corpus.
Identity. Variant identifiers are resolved to one organisation before its data is combined.
Identifiers
- Scrutica ID
- org-intellia-therapeutics-inc
Name forms resolved to this record: Intellia Therapeutics.